Cargando…

Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation

Combination immunotherapy treatments that recruit both innate and adaptive immunity have the potential to increase cancer response rates by engaging a more complete repertoire of effector mechanisms. Here, we combined intratumoral STimulator of INterferon Genes (STING) agonist therapy with systemica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milling, Lauren E., Garafola, Daniel, Agarwal, Yash, Wu, Shengwei, Thomas, Ayush, Donahue, Nathan, Adams, Josetta, Thai, Nikki, Suh, Heikyung, Irvine, Darrell J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732307/ https://www.ncbi.nlm.nih.gov/pubmed/34686488 http://dx.doi.org/10.1158/2326-6066.CIR-21-0247

Ejemplares similares

Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade
por: Wang, Chensu, et al.
Publicado: (2021)

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity
por: Dane, Eric L., et al.
Publicado: (2022)

Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
por: Zhang, Yuan, et al.
Publicado: (2018)

Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
por: Sriram, Ganapathy, et al.
Publicado: (2022)

ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade
por: Liu, Xiaolan, et al.
Publicado: (2023)

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021)

HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients
por: Zheng, Bingqing, et al.
Publicado: (2021)

STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models
por: Berger, Gilles, et al.
Publicado: (2022)

STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV(+) status in head and neck cancer
por: Lu, Shanhong, et al.
Publicado: (2018)

STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer
por: Da, Yanyan, et al.
Publicado: (2022)

Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
por: Moon, James J., et al.
Publicado: (2012)

Aneuploid senescent cells activate NF‐κB to promote their immune clearance by NK cells
por: Wang, Ruoxi W, et al.
Publicado: (2021)

STING activation in cancer immunotherapy
por: Su, Ting, et al.
Publicado: (2019)

The Emerging Role of NK Cells in Immune Checkpoint Blockade
por: Martinez-Perez, Alejandra, et al.
Publicado: (2022)

Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
por: Mehrabi, Maryam, et al.
Publicado: (2021)

Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance
por: Duan, Siqin, et al.
Publicado: (2022)

Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

TBK1 recruitment to STING mediates autoinflammatory arthritis caused by defective DNA clearance
por: Li, Tong, et al.
Publicado: (2021)

Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
por: Patterson-Fortin, Jeffrey, et al.
Publicado: (2023)

STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
por: Nakamura, Takashi, et al.
Publicado: (2021)

Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer
por: Yan, Xuewei, et al.
Publicado: (2022)

Activation of STING requires palmitoylation at the Golgi
por: Mukai, Kojiro, et al.
Publicado: (2016)

TIGIT blockade enhances NK cell activity against autologous HIV‐1‐infected CD4(+) T cells
por: Holder, Kayla A, et al.
Publicado: (2021)

Harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade
por: Patin, Emmanuel C, et al.
Publicado: (2022)

Ultrasound to the Rescue: Axillary Clearance under Complete Regional Blockade
por: Munasinghe, B. M, et al.
Publicado: (2021)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis
por: Ireland, Lucy, et al.
Publicado: (2020)

Optimization of an alum-anchored clinical HIV vaccine candidate
por: Rodrigues, Kristen A., et al.
Publicado: (2023)

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC
por: Taniguchi, Hirokazu, et al.
Publicado: (2022)

Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade
por: Wang, Minglei, et al.
Publicado: (2023)

Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma
por: Cai, Yiqing, et al.
Publicado: (2023)

Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
por: Draganov, Dobrin, et al.
Publicado: (2021)

A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017)

Dampened STING-Dependent Interferon Activation in Bats
por: Xie, Jiazheng, et al.
Publicado: (2018)

Activation of STING Based on Its Structural Features
por: Hussain, Behzad, et al.
Publicado: (2022)

Twenty-and-a-half syndrome: a case report
por: Dube, Mukesh, et al.
Publicado: (2019)

Co‐Anchoring of Engineered Immunogen and Immunostimulatory Cytokines to Alum Promotes Enhanced‐Humoral Immunity
por: Chang, Jason Y. H., et al.
Publicado: (2022)

The activity of disease-causative STING variants can be suppressed by wild-type STING through heterocomplex formation
por: Shindo, Ruri, et al.
Publicado: (2022)

Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model
por: Ren, Xiaoxin, et al.
Publicado: (2022)

PD-L1 blockade enhances anti-tumor efficacy of NK cells
por: Oyer, Jeremiah L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_osm9l8rkrrnm2sd1tngrq7klme